Delivery Order SPE2DB20D3103-SPE2DB25FP8M5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s under a firm fixed-price contract valued at $10,068.42. This non-competitive delivery order, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply relationship with DLA. The work will be performed at the contractor's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,205.36 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Lidocaine 5% patches (30-count). This competitively awarded, firm fixed price contract is scheduled for completion by August 18, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The order carries no set-aside designation and represents a small-value transaction within AmerisourceBergen's broader...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,363.52 for Lidocaine 5% Patch 30s, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. This delivery order is issued...
- The Defense Logistics Agency awarded a $17,105.21 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of July 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office as a leading pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a $2,317.23 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-set-aside, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a $2,761.61 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 31, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal contract vehicle. The pharmaceutical product will be performed and delivered from the vendor's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,504.37 for Lidocaine 5% Patch (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s under a firm fixed price contract valued at $1,669.23. The delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a small-value pharmaceutical procurement. This non-set-aside award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- The Defense Logistics Agency awarded a delivery order valued at $2,479.02 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of August 15, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order executed on August 14, 2025, and will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. The contract is a child award under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,041.56 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units. Issued on July 21, 2025, with completion scheduled for July 22, 2025, this firm fixed-price contract represents a small-value pharmaceutical supply order to support federal medical procurement needs. The award utilizes no set-aside designation and reflects competitive procurement practices. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP8M5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,055.24 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on August 12, 2025, with an ultimate completion date of August 13, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion global pharmaceutical support vehicle running through December 2026. This prime indefinite delivery vehicle enables AmerisourceBergen to supply a full spectrum of pharmaceutical products and medical supplies to support military healthcare programs and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. The delivery order represents a routine execution within the company's established framework as a major federal pharmaceutical distributor serving critical defense medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/12/25 |